The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Delayed recurrences and survival after relapse in patients initially treated with intraperitoneal chemotherapy for advanced ovarian cancer: A Gynecologic Oncology Group study.
 
Daniel Stuart Kapp
No Relationships to Disclose
 
James Java
No Relationships to Disclose
 
Thomas J. Herzog
No Relationships to Disclose
 
Maurie Markman
No Relationships to Disclose
 
Deborah Kay Armstrong
Consulting or Advisory Role - Eisai (I); eviti; Morphotek
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); Eisai (I); Exelixis (I); Genentech (Inst); Ventirx (Inst)
 
Bradley J. Monk
Consulting or Advisory Role - Advaxis; Amgen; AstraZeneca; Cerulean Pharma; GlaxoSmithKline; Gradalis; Merck; Roche/Genentech; Tesaro; Verastem
Speakers' Bureau - Roche/Genentech
Research Funding - Amgen (Inst); Array BioPharma (Inst); Genentech (Inst); Janssen (Inst); Lilly (Inst); Novartis (Inst); Tesaro (Inst)
 
John K. Chan
No Relationships to Disclose